V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20217066 | 20168697 | 1.92 | 84.9 | null | 2016-07-27 | 2016-07-28 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100789789 |
| 20217067 | 20168698 | 1.72 | 90.4 | Neo-adjuvant (N) | 2017-10-27 | 2017-11-14 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100618570 |
| 20217106 | 20168699 | 1.66 | 82.25 | Palliative (P) | 2019-07-09 | 2019-07-30 | EOX | 02 | N | EOX | 101305955 |
| 20217121 | 20168700 | 1.6 | 70.4 | Adjuvant (A) | 2018-11-26 | 2018-11-26 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101191812 |
| 20217128 | 20168701 | 1.72 | 90 | Palliative (P) | 2016-12-03 | 2016-12-22 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101809178 |
| 20217134 | 20168702 | 1.76 | 50 | null | 2017-07-21 | 2018-11-23 | EOX | 02 | N | CAPECITABINE + RT | 101540031 |
| 20217135 | 20168703 | 1.58 | 92.8 | Palliative (P) | 2019-05-28 | 2019-05-29 | EOX | 1 | Y | CETUXIMAB + IRINOTECAN + MDG | 100254772 |
| 20217145 | 20168704 | 1.74 | 102.4 | Curative (C) | 2017-09-09 | 2017-09-17 | Sorafenib | 02 | N | SORAFENIB | 100615031 |
| 20217178 | 20168705 | 1.67 | 58 | Palliative (P) | 2019-02-19 | 2019-03-05 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101051082 |
| 20217181 | 20168706 | null | 96.2 | null | 2019-04-16 | 2019-05-12 | EOX | 02 | Y | EOX | 101238447 |
| 20217200 | 20168707 | 1.54 | 93.8 | Palliative (P) | 2019-10-14 | 2020-02-12 | EOX | 02 | N | EOX | 101505933 |
| 20217211 | 20168708 | 1.76 | 79.5 | Palliative (P) | 2016-06-28 | 2016-07-28 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100599443 |
| 20217236 | 20168709 | 1.54 | 80.45 | Palliative (P) | 2017-09-19 | 2017-09-28 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101329666 |
| 20217242 | 20168710 | 1.63 | 62.9 | Adjuvant (A) | 2018-11-13 | 2019-01-01 | Trial Unspecified | 01 | N | TRIAL | 101160535 |
| 20217247 | 20168711 | 1.71 | 48.5 | Palliative (P) | 2020-04-09 | 2020-04-16 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101338189 |
| 20217256 | 20168712 | 1.72 | 0 | Palliative (P) | 2018-01-31 | 2018-01-31 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101612539 |
| 20217257 | 20168713 | 1.76 | 74.6 | null | 2019-02-22 | 2019-03-07 | Trial Unspecified | 99 | null | TRIAL | 100870469 |
| 20217259 | 20168714 | 1.69 | 82 | Palliative (P) | 2020-05-06 | 2020-05-20 | EOX | N | N | TRIAL | 101815664 |
| 20217273 | 20168715 | 1.72 | 80.1 | Palliative (P) | 2018-01-31 | 2019-01-11 | Trial Unspecified | 02 | N | TRIAL | 101016378 |
| 20217298 | 20168716 | 1.85 | 71.1 | Neo-adjuvant (N) | 2017-03-23 | 2017-03-23 | EOX | 02 | N | SORAFENIB | 100257752 |
| 20217310 | 20168717 | 1.72 | 114.2 | Palliative (P) | 2020-07-22 | 2020-07-22 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100104094 |
| 20217327 | 20168718 | 1.82 | 88.2 | 03 | 2019-02-05 | 2020-02-13 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100790028 |
| 20217333 | 20168719 | 1.81 | 82.3 | null | 2018-01-29 | 2018-01-31 | CAPECITABINE + RT | 02 | null | CAPECITABINE + RT | 100638633 |
| 20217342 | 20168720 | 1.69 | 75.5 | Palliative (P) | 2019-04-03 | 2019-06-30 | EOX | 99 | null | TRIAL | 100110204 |
| 20217351 | 20168721 | 1.8 | 72 | Palliative (P) | 2018-08-23 | 2018-12-30 | Capecitabine 35days + RT | 02 | null | CAPECITABINE + RT | 100628140 |
| 20217369 | 20168722 | 1.75 | 72 | Palliative (P) | 2020-08-15 | 2020-12-20 | Panitumumab + Irinotecan + MdG | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100902350 |
| 20217381 | 20168723 | 1.76 | 48.9 | Disease modification (D) | 2019-10-26 | 2019-12-01 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101505873 |
| 20217383 | 20168724 | 1.62 | 0 | Palliative (P) | 2020-01-09 | 2020-02-09 | Capecitabine 35days + RT | 1 | N | CETUXIMAB + IRINOTECAN + MDG | 100818464 |
| 20217386 | 20168725 | 1.78 | 64.2 | Palliative (P) | 2018-10-06 | 2018-10-06 | EOX | N | N | EOX | 101404860 |
| 20217398 | 20168726 | 1.62 | 64 | null | 2018-11-22 | 2019-04-26 | Trial Unspecified | 99 | N | TRIAL | 101847977 |
| 20217399 | 20168727 | 1.74 | 77.6 | Palliative (P) | 2019-12-07 | 2019-12-09 | Sorafenib | 02 | N | SORAFENIB | 100880908 |
| 20217400 | 20168728 | 1.63 | 93.1 | Palliative (P) | 2018-09-12 | 2019-04-14 | Cetuximab + FOLFIRI cycle1 | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 101741292 |
| 20217401 | 20168729 | 1.79 | 86 | 03 | 2019-04-03 | 2019-08-20 | Cetuximab + Oxaliplatin + MdG Load | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100662830 |
| 20217419 | 20168730 | 1.84 | 72 | Palliative (P) | 2016-06-23 | 2018-08-14 | Capecitabine 35days + RT | 2 | N | CAPECITABINE + RT | 100704174 |
| 20217439 | 20168731 | 1.59 | 77 | null | 2020-07-28 | 2020-08-09 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100767434 |
| 20217455 | 20168732 | null | 66.1 | null | 2018-02-26 | 2018-03-07 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + RT | 100146658 |
| 20217460 | 20168733 | 1.64 | 82.5 | Neo-adjuvant (N) | 2017-04-23 | 2019-04-10 | Sorafenib | 02 | N | SORAFENIB | 101335390 |
| 20217475 | 20168734 | 1.75 | 92.2 | Palliative (P) | 2018-04-05 | 2018-05-17 | Capecitabine 42days + RT | 02 | Y | CAPECITABINE + RT | 100839283 |
| 20217478 | 20168735 | 1.83 | 53.6 | Palliative (P) | 2019-08-15 | 2019-08-15 | Oxaliplatin + Raltitrexed | N | N | OXALIPLATIN + RALTITREXED | 100838033 |
| 20217485 | 20168736 | 1.7 | 73.9 | Palliative (P) | 2017-11-09 | 2017-11-13 | Capecitabine 35days + RT | 02 | null | CAPECITABINE + RT | 100024653 |
| 20217486 | 20168737 | 0 | 67.1 | Palliative (P) | 2017-08-26 | 2017-09-11 | EOX | 01 | N | CETUXIMAB + IRINOTECAN + MDG | 100374576 |
| 20217492 | 20168738 | 1.59 | 68 | Palliative (P) | 2018-08-03 | 2019-03-05 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100296646 |
| 20217517 | 20168739 | 1.79 | 84 | Palliative (P) | 2018-03-21 | 2018-04-25 | Sorafenib | 02 | N | SORAFENIB | 100533196 |
| 20217520 | 20168740 | 1.63 | 52 | Palliative (P) | 2019-03-30 | 2019-04-09 | Oxaliplatin + Raltitrexed | 01 | null | OXALIPLATIN + RALTITREXED | 100825938 |
| 20217543 | 20168741 | 1.75 | 120 | Palliative (P) | 2019-10-05 | 2019-10-06 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100024670 |
| 20217546 | 20168742 | 1.78 | 86.2 | null | 2018-01-07 | 2018-02-11 | EOX | N | null | EOX | 100122822 |
| 20217549 | 20168743 | 1.86 | null | Palliative (P) | 2019-05-14 | 2019-05-28 | Oxaliplatin + Raltitrexed | N | null | OXALIPLATIN + RALTITREXED | 101838665 |
| 20217552 | 20168744 | 1.51 | 60.5 | Curative (C) | 2017-12-31 | 2018-01-06 | EOX | N | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101496379 |
| 20217564 | 20168745 | 1.84 | 71.6 | Palliative (P) | 2017-07-15 | 2017-07-30 | Trial Unspecified | null | N | TRIAL | 100828834 |
| 20217565 | 20168746 | 1.75 | 50 | Palliative (P) | 2016-12-26 | 2017-01-16 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101607613 |